1. Home
  2. GGN vs FTRE Comparison

GGN vs FTRE Comparison

Compare GGN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GAMCO Global Gold Natural Resources & Income Trust

GGN

GAMCO Global Gold Natural Resources & Income Trust

HOLD

Current Price

$5.15

Market Cap

877.0M

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$13.31

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGN
FTRE
Founded
2005
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
877.0M
829.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
GGN
FTRE
Price
$5.15
$13.31
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$14.06
AVG Volume (30 Days)
438.3K
1.5M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
10.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$4.31
$3.97
52 Week High
$5.88
$18.67

Technical Indicators

Market Signals
Indicator
GGN
FTRE
Relative Strength Index (RSI) 37.15 55.18
Support Level $5.09 $8.85
Resistance Level $5.32 $18.26
Average True Range (ATR) 0.07 0.78
MACD -0.02 -0.23
Stochastic Oscillator 0.00 9.69

Price Performance

Historical Comparison
GGN
FTRE

About GGN GAMCO Global Gold Natural Resources & Income Trust

GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option planning of writing (selling) covered call options on equity securities in its portfolio.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: